The technical chart pattern of Amgen, Inc. shares shows signs of a reversal that argue in favor of a return to a positive outlook over the medium term. Investors have an opportunity to buy the stock and target the $ 157.4.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The group's activity appears highly profitable thanks to its outperforming net margins.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Historically, the company has been releasing figures that are above expectations.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
According to forecast, a sluggish sales growth is expected for the next fiscal years.
Based on current prices, the company has particularly high valuation levels.
Below the resistance at 153.21 USD, the stock shows a negative configuration when looking looking at the weekly chart.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.